Mountaingate Capital Acquires BioDerm

BioDerm (Mountaingate) Acquires Argentum Medical

February 1, 2023

Medical Devices

BioDerm, a portfolio company of Mountaingate Capital, has acquired Argentum Medical and combined the business with BioDerm to create a larger wound-care and infection-prevention platform. Mountaingate supported the combination through its existing ownership of BioDerm and new investment in the combined entity, with Five Points Capital providing unitranche financing to support the refinancing and acquisition; Shore Capital Partners sold Argentum.

Mountaingate Capital Invests in MeritDirect

May 29, 2019

Data & Analytics

Denver-based private equity firm Mountaingate Capital has made a private equity investment in MeritDirect, a Rye Brook, New York-based B2B database products and services provider. The investment will fund MeritDirect's organic growth and support strategic add-on acquisitions to expand its data and marketing capabilities.

DermBiont Acquires SeylanMED to Expand Dermatology Pipeline

October 21, 2020

Biotechnology

DermBiont, a Boston-based clinical-stage precision dermatology company, has acquired SeylanMED, adding a targeted topical AKT inhibitor gel candidate for seborrheic keratosis to its pipeline. The acquisition expands DermBiont's therapeutic modalities and accelerates its objective to develop targeted topical treatments and live bacterial therapeutics for skin diseases.

Merit Medical Systems Acquires Biolife Delaware

May 28, 2025

Medical Devices

Merit Medical Systems has acquired Biolife Delaware, a Sarasota, Florida-based maker of StatSeal and WoundSeal hemostatic devices, in a cash transaction valued at approximately $120 million (including assumed liabilities). The deal expands Merit's hemostasis and wound-care product portfolio and is expected to modestly impact 2025 non-GAAP profitability while enhancing Merit's ability to serve a broad set of percutaneous procedure end markets.

BioStem Technologies Acquires BioTissue's Surgical and Wound Care Business

January 22, 2026

Medical Devices

BioStem Technologies (OTC: BSEM) has acquired the surgical and wound care business of BioTissue Holdings, Inc. for approximately $15 million upfront, with up to $25 million of contingent milestone and royalty payments. The deal includes the Neox and Clarix product lines, a nationwide commercial sales organization and assigned GPO contracts, expanding BioStem's access into hospital inpatient and outpatient wound-care markets and adding assets that generated roughly $29 million in 2025.

DermCare Management Acquires Four Dermatology Practices

February 22, 2022

Healthcare Services

DermCare Management, a portfolio company of Hildred Capital Management, announced partnerships to bring Stone Oak Dermatology, Irradiance Medical Group, Altman Dermatology, and Icecreamwala Dermatology into its platform. The add-on deals expand DermCare’s footprint across Florida, Texas and California, increasing the platform to 46 locations and roughly 100 medical providers.